MT-II's effect on erectile function is primarily mediated through MC4R receptors, whose activation is associated with sexual behavior and libido in the central nervous system. Studies in animal models, particularly in rats, demonstrated that MT-II-induced erections were dose-dependent and linked to central, not peripheral, action. This central mechanism offers a distinct advantage over standard treatments, focusing on neurotransmitter pathways rather than vascular dilation. By modulating receptors within the brain, MT-II provides a novel approach to treating erectile dysfunction that could benefit patients unresponsive to traditional medications.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Melanotan 2 by Driada Medical, consult with your doctor or healthcare professional.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
Home
